Vyvgart may be safe, effective in treatment-resistant MG: Review

Vyvgart may be safe, effective in treatment-resistant MG: Review

People with refractory myasthenia gravis (MG) who fail to respond to several treatments may be effectively treated with Vyvgart (efgartigimod alfa-fcab), regardless of the type of self-reactive antibodies they carry. That’s according to a systematic review and meta-analysis, which showed that patients treated with Vyvgart saw their symptoms…

Registry data back Soliris, Ultomiris as safe, effective for gMG

Soliris (eculizumab) and Ultomiris (ravulizumab-cwvz) are generally safe and effective for easing symptoms of generalized myasthenia gravis (gMG) when used in everyday clinical practice. That’s according to data from the MG SPOTLIGHT Registry (NCT04202341), which was established to assess the long-term effectiveness of both therapies in…

Claseprubart shows good safety, signs of effectiveness in gMG trial

Treatment with the experimental injection therapy claseprubart (DNTH103) was well tolerated and appeared to ease symptoms of generalized myasthenia gravis (gMG) in a Phase 2 clinical trial involving people with the autoimmune neuromuscular condition. That’s according to top-line data announced by the therapy’s developer Dianthus Therapeutics. The…

We need to address verbal, sexual harassment in healthcare settings

Living with myasthenia gravis (MG) means I’ve spent more time in hospitals and clinics than I ever imagined I would. Most of the healthcare providers I’ve met have been kind, compassionate, and respectful. They’ve held my hand through scary procedures, explained complicated medical jargon in ways I could understand,…

Gently testing the limits of my MG with more activity

The first recommendation anyone gives you when you’re diagnosed with a chronic illness is always the same: rest. And for the past five years, I fully believed it. I told myself, and everyone else, that rest was the key to managing myasthenia gravis (MG). I built a life around…